Our CD5L mRNA expression data from pre-cirrhotic NAFLD liver biopsies indicate an increase in association with fatty liver disease which, again, is not altered by the grade of either fat or inflammation. This evidence concerns the gene CD5L and metabolic dysfunction-associated steatotic liver disease.